A hormone-depleting drug approved last year for the treatment of metastatic prostate cancer can help eliminate or nearly eliminate tumors in many patients with aggressive cancers that have yet to spread beyond the prostate, ...
May 16, 2012
0
0
Dying of a broken heart was just a figure of speech until 2002 when Dr. Hikaru Sato and colleagues at Hiroshima City Hospital described it in a study. Sato named the condition takotsubo cardiomyopathy. It was quickly dubbed ...
Jul 14, 2022
0
3
A new study from Karolinska Institutet shows that 45 genes may play a crucial role in the prognosis of patients with adrenal cancer. The findings, published in the journal ESMO Open, give hope for a better diagnostic tool ...
Jun 27, 2024
0
0
Researchers from across the globe have joined together to improve understanding about one of the most rare—and lethal—types of cancer.
May 9, 2016
0
11
(HealthDay)—Unituxin (dinutuximab) has been approved by the U.S. Food and Drug Administration to treat children with high-risk neuroblastoma, a rare cancer that most often affects children aged five and under.
Mar 11, 2015
0
6
An international team of scientists, including those at the Translational Genomic Research Institute (TGen), have discovered new avenues of potential treatments for a rare and deadly cancer known as Adrenocortical Carcinoma, ...
May 10, 2016
0
3
An international study, involving Newcastle University, has for the first time found a genetic marker in tumors from patients with high-risk neuroblastoma.
Jun 21, 2021
0
4
Cancer researchers in Würzburg, in cooperation with the international Cancer Genome Atlas Research Network, have identified new genetic drivers of adrenal cancer. Würzburg was the center of coordination of the European ...
May 30, 2016
0
1
Two University of Colorado Cancer Center studies presented at ENDO 2018 use new models to identify genetic targets and test promising treatments in adrenal cancer. One patient was treated with the immunotherapy pembrolizumab ...
Mar 19, 2018
0
1
